Abstract
The use of long-circulating colloidal carrier compositions comprising a corticosteroid and a lipid-polymer-conjugate, wherein the polymer is a poly((derivatised) amino acid) and optionally a further useful active ingredient, for the manufacture of a medicament useful in the treatment of non-lymphatic cancer and especially of solid (non-haematological) malignancies and metastases (solid primary and secondary tumors) is provided. Also provided are long-circulating colloidal carrier compositions comprising a corticosteroid in combination with a further drug or active ingredient that enhances the beneficial effect shown by the corticosteroid alone.
| Original language | English |
|---|---|
| Patent number | WO2004019914 |
| IPC | A61K 31/ 727 A I |
| Priority date | 27/08/02 |
| Publication status | Published - 11 Mar 2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Lipid-polymer-conjugates compositions comprising corticosteroids for the treatment of cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver